Demonstrações financeiras detalhadas de Nortech Systems Incorporated (NSYS): demonstração de resultados, balanço patrimonial e fluxo de caixa. Acompanhe a evolução de margens, dívida, liquidez e rentabilidade ano a ano com até 20 anos de histórico.
Resumo da Análise
Nortech Systems Incorporated registou receitas de $118.4M no último exercício, com um CAGR de 5 anos de 2.6%.
Margens dos últimos 12 meses: margem bruta 16.4%, margem operacional 2.0%, margem líquida 0.8%. O fluxo de caixa livre cresceu a CAGR de 19.8% em 5 anos.
Ao preço atual de $11.51, NSYS negocia a um P/L de 31.73 e um ROE de 2.99%. A capitalização de mercado é de $32M.
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Receita | $116.6M | $112.3M | $113.4M | $116.3M | $104.1M | $115.2M | $134.1M | $139.3M | $128.1M | $118.4M |
| Custo da Receita | $102.8M | $100.2M | $100.1M | $103.8M | $95.7M | $99.3M | $113.6M | $116.2M | $111.4M | $100.4M |
| Lucro Bruto | $13.8M | $12.1M | $13.3M | $12.6M | $8.5M | $15.9M | $20.5M | $23.1M | $16.7M | $18.0M |
| P&D | 0 | 0 | 0 | 0 | 0 | $483000 | $1.5M | $1.2M | $1.2M | $1.2M |
| Despesas Gerais e Administrativas | $13.2M | $12.8M | $12.1M | $12.4M | $10.5M | $12.4M | $15.1M | $16.0M | $15.2M | $15.6M |
| Despesas Operacionais | $13.2M | $12.8M | $12.1M | $12.4M | $10.5M | $13.6M | $16.6M | $17.2M | $16.9M | $16.8M |
| Lucro Operacional | $629063 | -$1.3M | $1.2M | $224000 | -$2.1M | $2.3M | $3.9M | $6.0M | -$195000 | $1.2M |
| EBITDA | $2.9M | $979443 | $3.4M | $2.4M | $1.6M | $10.4M | $5.8M | $8.0M | $1.5M | $2.3M |
| Despesas com Juros | $550289 | $627555 | $757000 | $1.0M | $620000 | $430000 | $411000 | $487000 | $744000 | $964000 |
| Lucro Antes de Impostos | $78774 | -$2.1M | $492000 | -$819000 | -$1.2M | $8.0M | $3.5M | $5.5M | -$939000 | $11000 |
| Imposto | $35000 | $375000 | $326000 | $409000 | $310000 | $859000 | $1.5M | -$1.4M | $356000 | $263000 |
| Lucro Líquido | $43774 | -$2.4M | $166000 | -$1.2M | -$1.5M | $7.2M | $2.0M | $6.9M | -$1.3M | -$252000 |
| LPA | $0.02 | $-0.89 | $0.06 | $-0.46 | $-0.58 | $2.68 | $0.75 | $2.53 | $-0.47 | $-0.09 |
| LPA Diluído | $0.02 | $-0.89 | $0.06 | $-0.46 | $-0.58 | $2.54 | $0.70 | $2.38 | $-0.47 | $-0.09 |
| Ações em Circulação (Diluídas) | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.8M | $2.9M | $2.9M | $2.8M | $2.8M |
Demonstração de Resultados (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Receita | $30.5M | $30.3M | $30.3M | $33.5M |
| Lucro Bruto | $5.0M | $5.1M | $4.7M | $5.7M |
| Lucro Operacional | $945000 | $901000 | $47000 | $623000 |
| EBITDA | $1.2M | $1.2M | $350000 | $623000 |
| Lucro Líquido | -$146000 | $897000 | -$34000 | $316000 |
| LPA | $-0.05 | $0.32 | $-0.01 | $0.11 |
| LPA Diluído | $-0.05 | $0.32 | $-0.01 | $0.11 |
Balanço (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caixa e Equivalentes | $268204 | $472886 | $480000 | $351000 | $352000 | $643000 | $1.0M | $960000 | $916000 | $1.7M |
| Investimentos de Curto Prazo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Contas a Receber | $17.5M | $17.6M | $26.5M | $26.2M | $21.5M | $28.5M | $28.6M | $33.8M | $28.7M | $32.2M |
| Estoque | $20.7M | $18.5M | $17.0M | $14.3M | $13.9M | $19.4M | $22.4M | $21.7M | $21.6M | $20.7M |
| Ativos Circulantes | $39.5M | $37.8M | $45.9M | $43.3M | $41.0M | $51.8M | $54.9M | $58.8M | $55.3M | $56.1M |
| Imobilizado | $10.3M | $10.2M | $10.2M | $14.4M | $15.4M | $14.8M | $14.3M | $13.4M | $14.4M | $12.2M |
| Ágio | $3.3M | $2.4M | $2.4M | $2.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Intangíveis | $1.9M | $1.7M | $1.5M | $1.3M | $1.2M | $501000 | $422000 | $263000 | $174000 | $156000 |
| Ativos Totais | $55.5M | $52.1M | $60.0M | $61.4M | $57.6M | $67.1M | $69.5M | $75.1M | $72.4M | $71.9M |
| Contas a Pagar | $13.8M | $11.7M | $18.1M | $14.0M | $11.2M | $12.7M | $14.8M | $15.9M | $11.6M | $12.8M |
| Dívida de Curto Prazo | $1.6M | $1.0M | $780000 | $444000 | $1.2M | 0 | 0 | 0 | 0 | $7.0M |
| Passivos Circulantes | $20.3M | $18.0M | $24.9M | $22.2M | $19.5M | $22.3M | $26.4M | $26.6M | $21.4M | $29.8M |
| Dívida de Longo Prazo | $12.2M | $12.9M | $12.9M | $13.3M | $9.2M | $9.0M | $6.9M | $5.8M | $8.6M | 0 |
| Passivos Totais | $33.2M | $32.3M | $38.9M | $41.4M | $38.9M | $41.0M | $41.5M | $39.8M | $38.4M | $37.4M |
| Reservas | $6.3M | $3.9M | $5.4M | $4.2M | $2.7M | $9.8M | $11.8M | $18.7M | $17.4M | $17.1M |
| Patrimônio Líquido | $22.3M | $19.8M | $21.1M | $20.0M | $18.7M | $26.1M | $28.1M | $35.3M | $34.0M | $34.5M |
| Dívida Total | $13.8M | $14.2M | $14.0M | $20.9M | $21.8M | $20.2M | $16.5M | $14.2M | $18.0M | $15.7M |
| Dívida Líquida | $13.5M | $13.7M | $13.5M | $20.6M | $21.4M | $19.6M | $15.5M | $13.2M | $17.1M | $14.1M |
| Capital de Giro | $19.2M | $19.7M | $21.0M | $21.1M | $21.5M | $29.5M | $28.5M | $32.2M | $33.9M | $26.3M |
Balanço (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caixa e Equivalentes | $1.3M | $1.7M | $2.0M | $1.4M |
| Ativos Totais | $74.8M | $71.9M | $76.6M | $80.0M |
| Passivos Totais | $41.4M | $37.4M | $41.9M | $44.6M |
| Patrimônio Líquido | $33.4M | $34.5M | $34.7M | $35.5M |
| Dívida Total | $21.1M | $15.7M | $18.0M | $17.9M |
Fluxo de Caixa (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Lucro Líquido | $43774 | -$2.4M | $166000 | -$1.2M | -$1.5M | $7.2M | $2.0M | $6.9M | -$1.3M | -$252000 |
| Depreciação e Amortização | $2.3M | $2.5M | $2.2M | $2.2M | $2.2M | $1.9M | $1.9M | $2.0M | $1.7M | $1.3M |
| Compensação em Ações | $994 | $43200 | $126000 | $261000 | $68000 | $259000 | $334000 | $423000 | $461000 | $503000 |
| Variação Capital de Giro | $1.7M | $711239 | -$319000 | -$796000 | $1.3M | -$9.4M | $1.4M | -$5.3M | -$3.2M | $1.4M |
| Fluxo de Caixa Operacional | $3.5M | $806245 | $2.4M | $997000 | $1.4M | -$4.5M | $5.4M | $1.8M | -$2.2M | $2.7M |
| CapEx | -$2.0M | -$927137 | -$1.4M | -$758000 | -$519000 | -$1.3M | -$2.4M | -$1.3M | -$1.3M | -$661000 |
| Aquisições | $3000 | $668786 | $14000 | 0 | 0 | 0 | 0 | 0 | 0 | $504000 |
| Recompra de Ações | 0 | -$30000 | -$276000 | -$130000 | 0 | 0 | 0 | 0 | -$100000 | 0 |
| Dividendos Pagos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | $1.6M | -$120892 | $1.0M | $239000 | $844000 | -$5.8M | $3.0M | $485000 | -$3.5M | $2.1M |
Fluxo de Caixa (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Fluxo de Caixa Operacional | -$92000 | $5.6M | -$1.6M | -$888000 |
| CapEx | -$150000 | -$661000 | -$228000 | -$95000 |
| Fluxo de Caixa Livre | -$242000 | $4.9M | -$1.8M | -$983000 |
| Dividendos Pagos | 0 | 0 | 0 | 0 |
| Compensação em Ações | $134000 | $134000 | $126000 | $194000 |
Crescimento e Margens (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crescimento Receita (anual) | | -3.7% | +0.9% | +2.6% | -10.5% | +10.6% | +16.5% | +3.9% | -8.0% | -7.6% |
| Crescimento Lucro Líquido (anual) | | -5687.3% | +106.8% | -839.8% | -25.9% | +562.7% | -71.9% | +242.0% | -118.8% | +80.5% |
| Crescimento LPA (anual) | | -4550.0% | +106.9% | -845.5% | -26.1% | +562.1% | -72.0% | +237.3% | -118.6% | +80.7% |
| Variação de Ações (anual) | | -0.1% | -1.7% | -1.3% | -0.3% | +6.2% | +2.5% | -0.2% | -4.4% | +0.7% |
| Crescimento FCF (anual) | | -107.7% | +960.3% | -77.0% | +253.1% | -791.0% | +150.8% | -83.6% | -825.8% | +159.1% |
| Margem Bruta | 11.9% | 10.8% | 11.7% | 10.8% | 8.1% | 13.8% | 15.3% | 16.6% | 13.1% | 15.2% |
| Margem Operacional | 0.5% | -1.1% | 1.1% | 0.2% | -2.0% | 2.0% | 2.9% | 4.3% | -0.2% | 1.0% |
| Margem EBITDA | 2.5% | 0.9% | 3.0% | 2.1% | 1.5% | 9.0% | 4.3% | 5.7% | 1.2% | 1.9% |
| Margem Líquida | 0.0% | -2.2% | 0.1% | -1.1% | -1.5% | 6.2% | 1.5% | 4.9% | -1.0% | -0.2% |
| Margem FCF | 1.4% | -0.1% | 0.9% | 0.2% | 0.8% | -5.1% | 2.2% | 0.3% | -2.7% | 1.8% |
| Taxa Efetiva de Imposto | 44.4% | -18.1% | 66.3% | -49.9% | -25.1% | 10.7% | 42.2% | -25.8% | -37.9% | 2390.9% |
Dados por Ação (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Ação | $0.57 | $-0.04 | $0.39 | $0.09 | $0.32 | $-2.07 | $1.02 | $0.17 | $-1.28 | $0.75 |
| Dividendo por Ação | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Ações em Circulação (Básicas) | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.8M | $2.8M |
O que olhar em Saúde / Farma
O pipeline de I+D é o ativo invisível. Patentes a caducar = receitas a evaporar. Olha inovação e fluxo de caixa.
- I+D / Receita — Indica investimento em pipeline futuro. Farma séria reinveste 15-20%
- Crescimento EPS 5 anos — Após expiração de patentes, ainda crescem?
- Margem bruta — Farma de marca >70%. Genéricos muito mais baixo — define o tipo de negócio
- FCF / Net Income — Qualidade do lucro — farma grande deveria converter >90%
- ROIC — Capital reinvestido com eficiência — chave em farma por ciclos longos de I+D
- Dívida líquida / EBITDA — Aquisições farmacêuticas geram muita dívida — atenção ao pós-M&A
- P/E vs histórico 10 anos próprio — A melhor comparação é com o próprio histórico, não com pares
Rentabilidade
| Retorno sobre patrimônio | 2.99% |
| Retorno sobre capital investido | 3.08% |
| Retorno sobre ativos | 1.29% |
| Margem bruta | 16.44% |
| Margem operacional | 2.02% |
| Margem líquida | 0.83% |
Saúde financeira
| Dívida / Patrimônio | 0.50 |
| Liquidez corrente | 1.78 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 2.81 |
Índices Chave (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/L | 194.50 | -4.34 | 57.54 | -10.59 | -12.36 | 3.86 | 16.33 | 3.72 | -21.89 | -81.83 |
| P/VP | 0.48 | 0.53 | 0.45 | 0.65 | 1.02 | 1.06 | 1.17 | 0.73 | 0.83 | 0.60 |
| P/V | 0.09 | 0.09 | 0.08 | 0.11 | 0.18 | 0.24 | 0.25 | 0.18 | 0.22 | 0.17 |
| Margem Bruta | 11.9% | 10.8% | 11.7% | 10.8% | 8.1% | 13.8% | 15.3% | 16.6% | 13.1% | 15.2% |
| Margem Operacional | 0.5% | -1.1% | 1.1% | 0.2% | -2.0% | 2.0% | 2.9% | 4.3% | -0.2% | 1.0% |
| Margem Líquida | 0.0% | -2.2% | 0.1% | -1.1% | -1.5% | 6.2% | 1.5% | 4.9% | -1.0% | -0.2% |